BIOMAT Database Logo BIOMAT Database Logo

[Pharmacologic aspects of prophylactic treatment of coronary disorders]. 1971

R E Nitz, and K Resag, and J Scholtholt

UI MeSH Term Description Entries
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

R E Nitz, and K Resag, and J Scholtholt
Prophylactic pharmacologic treatment of asthma.
December 1992, Allergy,
R E Nitz, and K Resag, and J Scholtholt
[Pharmacologic aspects of sleep disorders].
January 1989, Comptes rendus des seances de la Societe de biologie et de ses filiales,
R E Nitz, and K Resag, and J Scholtholt
[Coronary surgery--prophylactic aspects].
November 1983, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
R E Nitz, and K Resag, and J Scholtholt
Pharmacologic treatment of tic disorders.
January 2000, Child and adolescent psychiatric clinics of North America,
R E Nitz, and K Resag, and J Scholtholt
Pharmacologic treatment of eating disorders.
December 1984, The Psychiatric clinics of North America,
R E Nitz, and K Resag, and J Scholtholt
Pharmacologic treatment of eating disorders.
April 2002, Canadian journal of psychiatry. Revue canadienne de psychiatrie,
R E Nitz, and K Resag, and J Scholtholt
Pharmacologic Treatment of Eating Disorders.
June 2019, The Psychiatric clinics of North America,
R E Nitz, and K Resag, and J Scholtholt
Pharmacologic treatment of phobic disorders.
September 1986, The Journal of clinical psychiatry,
R E Nitz, and K Resag, and J Scholtholt
Pharmacologic treatment of neuropsychiatric disorders.
January 1993, NeuroRehabilitation,
R E Nitz, and K Resag, and J Scholtholt
Pharmacologic treatment of anxiety disorders.
December 1982, The Journal of clinical psychiatry,
Copied contents to your clipboard!